Hero

Celyad Announces Pricing of $20.0 Million Global Offering

1

Celyad Announces Pricing of $20.0 Million Global Offering

Celyad Announces Launch of Proposed Global Offering

2

Celyad Announces Launch of Proposed Global Offering

Celyad Successfully Doses First Patient with CYAD-01 Produced with OptimAb Manufacturing Process

3

Celyad Successfully Doses First Patient with CYAD-01 Produced with OptimAb Manufacturing Process

Celyad to Participate in Upcoming September 2019 Conferences

4

Celyad to Participate in Upcoming September 2019 Conferences

About Celyad

Making the Impossible Possible

Celyad is a clinical-stage biopharmaceutical that is developing next generation CAR-T NK cell-based immunotherapies for cancer treatment.

Latest News

Celyad Announces Pricing of $20.0 Million Global Offering

Celyad Announces Pricing of $20.0 Million Global Offering

Celyad Announces Launch of Proposed Global Offering

Celyad Announces Launch of Proposed Global Offering

Celyad Successfully Doses First Patient with CYAD-01 Produced with OptimAb Manufacturing Process

Celyad Successfully Doses First Patient with CYAD-01 Produced with OptimAb Manufacturing Process

Discover all news

Carousel

Social Feed

Sarah Snykers, QC Manager at Celyad will be presenting at the Cell & Gene Therapy Bioprocessing & Commercialization… https://t.co/8KhC33GmaY

6 days ago

Sarah Snykers, QC Manager at Celyad will be presenting at the Cell & Gene Therapy Bioprocessing & Commercialization… https://t.co/8KhC33GmaY

#BloodCancerAwarenessMonth https://t.co/4voF2HfepQ

6 days ago

#BloodCancerAwarenessMonth https://t.co/4voF2HfepQ

@ElenaSpanjaard, Head of Regulatory Affairs at Celyad will be presenting at the CAR-TCR summit ! #CARTCRsummit $CYAD https://t.co/7dxkIzkmED

6 days ago

@ElenaSpanjaard, Head of Regulatory Affairs at Celyad will be presenting at the CAR-TCR summit ! #CARTCRsummit $CYAD https://t.co/7dxkIzkmED

September is #BloodCancerAwarenessMonth ! Spread the word by retweeting this post. https://t.co/oUjIcVrvhz

1 week ago

September is #BloodCancerAwarenessMonth ! Spread the word by retweeting this post. https://t.co/oUjIcVrvhz

Sarah Snykers, QC Manager at Celyad will be presenting at the Cell & Gene Therapy Bioprocessing & Commercialization… https://t.co/8KhC33GmaY

6 days ago

Sarah Snykers, QC Manager at Celyad will be presenting at the Cell & Gene Therapy Bioprocessing & Commercialization… https://t.co/8KhC33GmaY

#BloodCancerAwarenessMonth https://t.co/4voF2HfepQ

6 days ago

#BloodCancerAwarenessMonth https://t.co/4voF2HfepQ

@ElenaSpanjaard, Head of Regulatory Affairs at Celyad will be presenting at the CAR-TCR summit ! #CARTCRsummit $CYAD https://t.co/7dxkIzkmED

6 days ago

@ElenaSpanjaard, Head of Regulatory Affairs at Celyad will be presenting at the CAR-TCR summit ! #CARTCRsummit $CYAD https://t.co/7dxkIzkmED

September is #BloodCancerAwarenessMonth ! Spread the word by retweeting this post. https://t.co/oUjIcVrvhz

1 week ago

September is #BloodCancerAwarenessMonth ! Spread the word by retweeting this post. https://t.co/oUjIcVrvhz